Insights On Pharmaceutical Packaging

1. Bringing A Biosimilar For Oncology To Market: Injectable Packaging From Early Development To Commercialization 2/20/2024

   While in their early-stage development of a mAb biosimilar for oncology treatment, a large biopharmaceuticals company sought a packaging recommendation: a stopper to maintain high-quality standards.

2. Low Temperature Storage Containment For Vial And Syringe Systems 6/20/2025

   With the growth of advanced therapy medicinal products, there is an increased need for specialized low-temperature packaging solutions, particularly for vials and syringe systems at -50°C to ≤ -130°C.

3. How To Optimize Labeling In A Pharmaceutical Environment 5/29/2025

   Accurate, readable pharmaceutical labels are crucial. Learn to navigate considerations like printing, application tolerances, and inspection to select the right machinery for your production environment.

4. Human Factors Testing: Engaging End-Users In Med Device Development 3/11/2025

   Explore the significance of human factors in the development of medical devices through an illustration of how important it is to incorporate the end users in the device development process.

5. FAQs On The Revised EU GMP Annex 1: Volume 1 3/5/2025

   The revised GMP Annex 1 guidelines emphasize quality risk management, enhanced environmental monitoring, and data integrity, which aim to minimize contamination and ensure patient safety.

6. Establishing And Safeguarding Shelf Life In Combination Products 10/27/2025

   Establishing combination product shelf life requires aligning stability. Holistic, data-driven stability studies ensure product function, safety, and label claims through the entire supply chain.

7. PCI Pharma Services Capabilities Update January 2026: Fill/Finish 1/27/2026

   Patricia Krainski highlights PCI’s global sterile fill‑finish and lyophilization strengths, showcasing investments that expand capacity, technologies, and integrated solutions for complex biologics, formulations, and lyophilized products.

8. Supporting GLP-1 And Peptides With Integrated Solutions 9/30/2025

   Accelerate GLP-1 and peptide therapy development with integrated drug containment, delivery, machinery, and analytics for reliable combination product performance.

9. FAQs On The Revised EU GMP Annex 1: Volume 2 3/5/2025

   Review the implementation of a holistic Contamination Control Strategy (CCS). Discover four key considerations for assessing component readiness: product, process, protection, and proof.

10. Film Sealing In Automation 6/16/2025

    Explore essential considerations for choosing the right sealing method in product development with insights on the benefits and drawbacks of different techniques for various industries.